About Saama
Saama Technologies focuses on clinical trial analytics for the life sciences sector, offering the Life Science Analytics Cloud (LSAC) that utilizes artificial intelligence to provide insights throughout the clinical trial process. Their solutions help pharmaceutical companies and contract research organizations (CROs) streamline workflows and automate tasks, allowing professionals to concentrate on critical data for better decision-making. Unlike competitors, Saama operates on a software-as-a-service (SaaS) model, providing continuous updates and improvements through subscription fees. The company's goal is to enhance efficiency, reduce costs, and accelerate drug development timelines.
Campbell, CaliforniaHeadquarters
1997Year Founded
$491.2MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Data & Analytics, Enterprise Software, BiotechnologyIndustries
1,001-5,000Employees
Risks
Rapid AI advancements could increase competition, eroding Saama's market share.
Reliance on strategic partnerships poses risks if partners develop in-house solutions.
New CEO's strategic shifts may disrupt operations or alienate existing clients.
Differentiation
Saama's LSAC platform offers AI-driven insights across the entire clinical trial process.
The company automates data quality checks, reducing manual work and enhancing decision-making.
Saama's strategic partnerships with Pfizer and AstraZeneca expand its AI-driven solutions' reach.
Upsides
Generative AI integration streamlines workflows and reduces clinical development delays.
AI-driven data quality automation ensures data integrity and reduces manual errors.
Recognition as a leader in industry assessments highlights Saama's competitive edge.
Funding
Total raised$491.23 M
Latest valuation$200.00 M
StageGROWTH_EQUITY_VC
LATE VC
2/28/2019$40
$200.00 MSERIES A
5/31/2015$35
$175.00 M